STROOOOOOOOOOOOOOONG BUY
https://*********.com.au/antisense-positive-early-results-clinical-trial-new-drug-duchenne-muscular-dystrophy/
The trial’s secondary endpoints assessed drug activity and efficacy and Antisense said it was “highly encouraged” that data to date is indicative of drug effect, “particularly considering the small number of patients evaluated and that the progress of the final three patients (due to complete dosing in November) appears consistent with this view that the drug is showing activity”.
Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-76
-
- There are more pages in this discussion • 520 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.015(13.0%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 12.0¢ | $612.7K | 4.843M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56662 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 600000 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |